Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical Inc (NQ: NARI )

62.45 +1.28 (+2.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 580,646
Open 61.21
Bid (Size) 60.02 (1)
Ask (Size) 62.85 (5)
Prev. Close 61.17
Today's Range 60.95 - 62.69
52wk Range 50.50 - 95.39
Shares Outstanding 54,313,676
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Shares of Inari Medical Rose This Week
The medical equipment maker's stock has climbed by $10 a share since the start of the month. 
Via The Motley Fool
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System
From Inari Medical, Inc.
Via Globe NewsWire

Performance

YTD
+2.82%
+2.82%
1 Month
+8.87%
+8.87%
3 Month
-0.46%
-0.46%
6 Month
-9.82%
-9.82%
1 Year
-30.80%
-30.80%

More News

Read More
Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Inari Medical, Inc.
Via Globe NewsWire
3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street
Via The Motley Fool
Analyst Expectations for Inari Medical's Future
Via Benzinga
What 6 Analyst Ratings Have To Say About Inari Medical
Via Benzinga
Analyst Ratings for Inari Medical
Via Benzinga
Where Inari Medical Stands With Analysts
Via Benzinga
Earnings Scheduled For February 27, 2023
Via Benzinga
Inari Medical Earnings Preview
Via Benzinga
Analyst Ratings for Inari Medical
Via Benzinga
Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
From Inari Medical, Inc.
Via Globe NewsWire
Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Inari Medical, Inc.
Via Globe NewsWire
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023
Via The Motley Fool
Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis
From Inari Medical, Inc.
Via Globe NewsWire
Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
From Inari Medical, Inc.
Via Globe NewsWire
3 Remarkable Growth Stocks That Could Climb 39% to 46%, According to Wall Street
Via The Motley Fool
Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Inari Medical, Inc.
Via Globe NewsWire
2 Top Growth Stocks Down 42.6% and 68.5% to Buy Before They Rebound in 2023
Via The Motley Fool
Inari Medical to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Inari Medical, Inc.
Via Globe NewsWire
Inari Medical Reports Third Quarter 2022 Financial Results
From Inari Medical, Inc.
Via Globe NewsWire
Inari Medical Announces In-hospital and 30-day Outcomes from the Fully Enrolled CLOUT Registry and Results from Propensity-Score Matched Comparison of CLOUT vs. ATTRACT
From Inari Medical, Inc.
Via Globe NewsWire
Where Inari Medical Stands With Analysts
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Via Benzinga
Inari Medical to Announce Third Quarter 2022 Financial Results
From Inari Medical, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.